Monoclonal antibodies - Therapeutic Classification

Monoclonal antibodies - Drugs


Generic Name(s)	Strength	Dosage Form	ICD Code
Benralizumab	30 mg / ml	Injection
Brodalumab	210mg/1.5ml	Injection
Burosumab-twza	10 mg/ml, 20 mg/ml, 30 mg/ml	Injection
Canakinumab	180mg/1ml	Injection	Y43.4
Capromab Pendetide			Y43.4
Certolizumab	200mg per 1 mL	Injection	Y43.4
Cetuximab	100mg/50 mL,200mg/100 mL	Injection	Y43.4
Denosumab	60mg/mL	Injection	Y43.4
Dupilumab	300mg / 2ml	Injection
Durvalumab	500 mg/10 ml, 120 mg/2.4 ml	Injection
Eculizumab	10 mg/mL	Injection	Y43.4
Emicizumab-kxwh	30 mg/ml, 150 mg/ml	Injection
Erenumab-aooe	70 mg/ ml	Injection
Fremanezumab-vfrm	225 mg/1.5 ml	Injection
Galcanezumab-gnlm	120 mg/ml	Injection
Golimumab	0.5ml/50mg	Injection	Y43.4
Ibalizumab-uiyk	200 mg/ 1.33 ml (150 mg/ ml)	Injection
Ipilimumab	5mg/mL	Injection	Y43.4
Lanadelumab-flyo	300 mg/2ml	Injection
Mepolizumab	100mg/Vial	Injection
Mogamulizumab-kpkc	20 mg/5 ml	Injection
Necitumumab	800 mg/50 ml	Injection
Nimotuzumab	50 mg/ 10ml	Injection
Ocrelizumab	30 mg/ml	Injection
Ofatumumab	100mg/5 mL, 1,000mg/50 mL	Injection	Y43.4
Omalizumab	150mg/Vial	Injection	Y43.4
Palivizumab	50mg per 0.5 mL and 100mg per 1 mL.	Injection	Y43.4
Panitumumab Injection	20mg/mL- single-use Vial	Injection	Y43.4
Pertuzumab	30 mg/mL	Injection	Y43.4
Rituximab	100 mg/10 mL, 500 mg/50 mL	Injection	Y43.4
Tildrakizumab-asmn	100 mg/ml	Injection
Ustekinumab	45mg/0.5 mL, 90mg/1 mL, 45mg/0.5 mL , 90mg/1 mL single use vial	Injection	Y43.4